Verastem Inc (VSTM) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Verastem Inc   (NASDAQ: VSTM)


Verastem Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Verastem Inc 's ROA in the second quarter of 2026?
Verastem Inc recorded a cumulative net loss of $-203 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -94.54%.

However, within the Healthcare sector 719 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4226, from total ROA ranking in the first quarter of 2026 at 4988.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 5.14 % 74.13 % 143.44 % 39.88 % 85.27 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -203 -194 -209 -241 -167
Return On Assets (TTM) -94.54 % -91.54 % -111.65 % -159.35 % -120.07 %
VSTM's Total Ranking # 4226 # 4988 # 4532 # 4514 # 4625
Total Assets (TTM) in million 206 228 246 177 196
Seq. Total Assets Change -9.51 % -7.46 % 39.41 % -9.93 % 49.86 %
Seq. Net Income Change - - - - -

VSTM's 5 Years Annual ROA >> Back to VSTM Management Effectiveness >> Compare VSTM ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 331
Sector # 720
Overall # 4193

Return On Assets Statistics
High Average Low
-24.43 %
-62.37 %
-159.05 %
(Jun 30 2021)   (Sep 30 2025)



  News about Verastem Inc Return on Assets ROA

Verastem Incs Stock Soars as Promising Clinical Trials and Positive Research Reports Boost Investor Confidence

Verastem Inc (NASDAQ: VSTM) has witnessed a surge in its stock price recently, driven by a series of positive developments. From a boost in price targets by leading research firms to the initiation of groundbreaking clinical trials in China, the biopharmaceutical company is making significant strides in its pursuit of innovative cancer therapies. This article aims to highlight the key events and their impact on Verastem Inc and the broader biopharmaceutical market.Verastem Inc s Stock Rating Upgraded and Price Target Raised:Leading research firm BTIG Research recently upgraded Verastem Inc s stock rating to a Buy, while also raising its price target. This positive assessment reflects confidence in the company s prospects and may attract more investors seeking promising opportunities in the biopharmaceutical sector. Such endorsements often result in a surge in stock prices, indicating growing market confidence in Verastem Inc s future potential.



Financial Statements
Verastem Inc 's Assets $ 206 million VSTM's Balance sheet
Verastem Inc 's Income $ -35 million Quarterly VSTM's Income Statement
VSTM's Income by Division See VSTM's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 143.44 % -32.04 % 56.47 % -11.18 % -30.55 %
Total Assets in million 246 101 149 95 107
Y / Y Net Income Change - - - - -
Net Income in million -209 -131 -87 -74 -71
Annual Return On Assets -85 % -129.04 % -58.65 % -77.53 % -66.42 %

VSTM's 5 Years Annual ROA >> Back to VSTM Management Effectiveness >> Compare VSTM ROA to its Competitors



More Return On Assets Ratios
VSTM's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VSTM's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VSTM's Competitors
Subscribers only: Roa for Verastem Inc 's Suppliers
Subscribers only: Return On Assets for VSTM's Customers

You may also want to know
VSTM's Roi VSTM's Inventory Turnover Ratio VSTM's Growth Rates VSTM's Dividend Comparisons
VSTM's Profitability Ratios VSTM's Asset Turnover Ratio VSTM's Dividend Growth
VSTM's Roe VSTM's Valuation Ratios VSTM's Financial Strength Ratios VSTM's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T15:11:45+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.